Washington [US], September 19 (ANI): US President Donald Trump on Friday (local time) said that his administration expects to have enough doses of coronavirus vaccines for every American citizen by April 2021.
Washington [US], September 18 (ANI): A top US health official has said that Congress needs to provide about USD 6 billion to help the country prepare for what is expected to be the largest COVID-19 vaccination campaign ever undertaken, Washington Post reported.
Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.
Madrid [Spain], September 14 (ANI): Spain's first trials of a coronavirus vaccine are scheduled to begin on September 14, Alberto Borobia, the chief of the clinical trials unit of the La Paz University Hospital in Madrid, said on Sunday.
Tehran [Iran], September 13 (ANI/Xinhua): Iranian medical scientists will soon start human trials for an anti-coronavirus vaccine after the stage of animal trials has passed, official news agency IRNA reported on Saturday.
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Brasilia [Brazil], September 10 (ANI/Sputnik): The Brazilian state of Bahia has signed an agreement with Russia for access to data on the Russian COVID-19 vaccine, Sputnik V, and intends to conduct its clinical trials, the Folha de Sao Paulo newspaper reported.
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
Caracas [Venezuela], September 9 (ANI/Sputnik): Venezuelan President Nicolas Maduro said Russia's Sputnik-V vaccine against the novel coronavirus disease (COVID-19) would be delivered to Venezuela in September 2020 for clinical trials.